Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

MBVI vs MEVO: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MBVI Wins Head-to-Head Institutional Verdict (2–0 across 6 Pillars · 7–1 Matrix Metrics)

MBVI Overall Winner 6-Pillar Tally: MBVI 2 – 0 MEVO (4 Tie) Matrix Metrics: MBVI 7 – 1 MEVO

As of Nov 20, 2026, MBVI (MBVI) is the stronger overall head-to-head candidate over MEVO (MEVO) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 2–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). MBVI carries a Unified Composite Score of 47.4/100 (HOLD) at $10.30 (N/M Forward P/E, 0.0% operating margin), whereas MEVO carries 54.9/100 (HOLD) at $10.05 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While MEVO currently prints a higher short-term Unified Composite Score (54.9/100 HOLD vs. MBVI 47.4/100 HOLD), MBVI captures the overall institutional head-to-head verdict (7–1 matrix metrics and 2–0 across the 6 pillars) due to superior fundamental profitability (0.0% vs. N/A operating margin) and revenue trajectory (+0.0% vs. N/A YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MBVI vs MEVO
MBVI US Equity Head-to-Head Winner
MBVI
Institutional Equity
$10.30
+0.05% 1D
Market Cap $444.2M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.02β · 1% Vol
Unified Composite Score
47.4 / 100 HOLD
Tech 35.0 Fund 37.0 Flow 50.0 Mom 25.9
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 73
RSI-14: 72.9 · SMA20: $10.28 · SMA50: $10.25
MEVO US Equity
MEVO
Institutional Equity
$10.05
+0.1% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.02β · 3% Vol
Unified Composite Score
54.9 / 100 HOLD
Tech 50.0 Fund 48.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A

6-Pillar Scorecard Institutional Category Breakdown (MBVI 2 – 0 MEVO)

Columns: Metric · MBVI · MEVO
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale MBVI
Revenue Growth (YoY) +0.0% N/A
Earnings Growth (YoY) +39.8% N/A
TTM Revenue (USD) N/A N/A
Market Cap $444.2M N/A
3. Profitability & Quality MBVI
Gross Margin N/A N/A
Operating Margin 0.0% N/A
Net Profit Margin 0.0% N/A
Return on Equity (ROE) 0.0% N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage 0.0% ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Shell Companies Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MBVI (7) vs MEVO (1)
Institutional Metric MBVI MEVO Criterion Row Edge
Market Capitalization
Scale
$444.2M N/A Larger Scale MBVI
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% N/A Higher Growth MBVI
Operating Margin (TTM)
Profitability
0.0% N/A Higher Margin MBVI
Net Profit Margin
Profitability
0.0% N/A Higher Margin MBVI
Return on Equity (ROE)
Capital Efficiency
0.0% N/A Higher ROE MBVI
52-Week Range Position
Momentum
62% ($10–$10) 17% ($10–$11) Stronger Trend MBVI
Beta / 30D Volatility
Risk Regime
0.02β · 1% Vol 0.02β · 3% Vol Lower Realized Risk MBVI
Unified Institutional Score
Composite Signal
47.4 / 100 (HOLD) 54.9 / 100 (HOLD) Higher Composite MEVO
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (0.0% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MBVI +0.28 pp
MBVI: +0.68% · MEVO: +0.4%
3M Horizon MBVI +0.37 pp
MBVI: +1.68% · MEVO: +1.31%
6M Horizon MBVI +0.35 pp
MBVI: +2.28% · MEVO: +1.93%
1Y Horizon MBVI +0.35 pp
MBVI: +2.28% · MEVO: +1.93%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MBVI vs MEVO. Trailing 12-month operating profitability (MBVI 0.0% vs MEVO N/A) and valuation multiples (MBVI N/M vs MEVO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

MBVI ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M
MEVO ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MBVI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MBVI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MEVO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MEVO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MBVI Moat Profile Cyclical / Execution-Driven Positioning
Shell Companies Operator
Competes within the Shell Companies value chain with $444.2M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
MEVO Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ MBVI vs MEVO Key Questions & Quantitative Answers

As of Nov 20, 2026, MBVI (MBVI) is the stronger overall head-to-head candidate over MEVO (MEVO) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 2–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). MBVI carries a Unified Composite Score of 47.4/100 (HOLD) at $10.30 (N/M Forward P/E, 0.0% operating margin), whereas MEVO carries 54.9/100 (HOLD) at $10.05 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While MEVO currently prints a higher short-term Unified Composite Score (54.9/100 HOLD vs. MBVI 47.4/100 HOLD), MBVI captures the overall institutional head-to-head verdict (7–1 matrix metrics and 2–0 across the 6 pillars) due to superior fundamental profitability (0.0% vs. N/A operating margin) and revenue trajectory (+0.0% vs. N/A YoY).

MBVI leads the Growth & Scale pillar: MBVI posts +0.0% YoY revenue growth and +39.8% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with MEVO at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, MBVI generates N/A in USD-normalized revenue versus N/A for MEVO. In operating R&D and SG&A reinvestment, MBVI deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for MEVO.

MBVI and MEVO trade at balanced relative valuation multiples. MBVI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas MEVO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MBVI (0.0% ROE) versus MEVO (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, MBVI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 1% Vol realized risk). By comparison, MEVO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 3% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.